# Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-upadacitinib-vs-dupilumab-in-adults-with-moderate-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrew Blauvelt,Henrique D. Teixeira,Eric L. Simpson,Antonio Costanzo,Marjolein de Bruin‐Weller,S. Barbarot,Vimal H. Prajapati,Peter Lio,Xiaofei Hu,Tianshuang Wu,John Liu,Barry Ladizinski,Alvina D. Chu,Kilian Eyerich |
| Citations | 494 |
| DOI | 10.1001/jamadermatol.2021.3023 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://jamanetwork.com/journals/jamadermatology/articlepdf/2782803/jamadermatology_blauvelt_2021_oi_210044_1639151709.9087.pdf |
| OpenAlex ID | https://openalex.org/W3189956257 |
| PMID | 34347860 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Marjolein de Bruin‐Weller](https://scholariq.org/researchers/marjolein-de-bruin-weller/)
- [Antonio Costanzo](https://scholariq.org/researchers/antonio-costanzo/)
- [Peter Lio](https://scholariq.org/researchers/peter-lio/)
- [Kilian Eyerich](https://scholariq.org/researchers/kilian-eyerich/)

## Paper journal

- [JAMA Dermatology](https://scholariq.org/journals/jama-dermatology/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.